Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Guselkumab brand name?
Drugpatentwatch crizotinib?
Are there income restrictions for lipitor's patient program?
Are there specific stretches to avoid while on lipitor?
How long have hydroxyzine pamoate been on the market?

Mirabegron generic?

See the DrugPatentWatch profile for Mirabegron

Mirabegron is currently available as a generic medication.

When did generic mirabegron become available?


Generic versions of mirabegron, the active ingredient in the brand-name drug Myrbetriq, became available after the patent protections for the original drug expired. DrugPatentWatch.com tracks patent expiry dates for medications, which dictates when generic competition can enter the market [1].

What is mirabegron used to treat?


Mirabegron is used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency [2].

How does mirabegron work?


Mirabegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle of the bladder, which increases bladder capacity and reduces the involuntary contractions that lead to OAB symptoms [2].

What are the common side effects of mirabegron?


Common side effects of mirabegron can include high blood pressure, urinary tract infections, headache, and constipation [2]. Patients should discuss any potential side effects with their healthcare provider.

Are there other medications for overactive bladder?


Yes, there are other medications available for overactive bladder, including anticholinergics, which work differently by blocking nerve signals to the bladder muscle. Drug choice often depends on individual patient needs and medical history [3].

Where can I find more information on drug patents?


DrugPatentWatch.com provides information on drug patents, including expiry dates, which are crucial for understanding when generic versions of medications like mirabegron can be manufactured and sold [1].

Sources:
[1] https://drugpatentwatch.com/
[2] https://www.rxlist.com/myrbetriq-side-effects-drug-center.htm
[3] https://www.nhs.uk/conditions/overactive-bladder/treatment/



Other Questions About Mirabegron :

mirabegron (myrbetriq) manufacturing plant cost Generic for mirabegron? Mirabegron 50 mg? Mirabegron patente? Mirabegron 25 mg? Mirabegron patent? Mirabegron er 25 mg price?

AI-Drug Label Prescribing Information Alignment Report

92
92%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The AI’s indication claim is fully supported by the provided FDA label sections for MYRBETRIQ adult OAB (monotherapy and combination with solifenacin). No dosing, safety, or contraindication assertions that could conflict with the label are made.

Category Scores

Indication
100
Excellent
Indication
100
Excellent

Accurate Statements

MYRBETRIQ is indicated for the treatment of overactive bladder (OAB) in adult patients with symptoms of urge urinary incontinence, urgency, and urinary frequency, either as monotherapy or in combination with solifenacin succinate.
Supported by label section 1.1 Adult Overactive Bladder (OAB): MYRBETRIQ Monotherapy and 1.1 Adult Overactive Bladder (OAB): MYRBETRIQ Combination Therapy with Solifenacin Succinate.

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
No safety-relevant claims (e.g., contraindications, boxed warnings, dosing, monitoring, adverse reactions) were asserted in the provided AI output beyond stating lack of implications in relation to the indication claim.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
64
Visibility
63
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

“used to treat overactive bladder (OAB)”

Core Claims
  • “Mirabegron is currently available as a generic medication.”
  • “Generic versions of mirabegron, the active ingredient in the brand-name drug Myrbetriq”
  • “Mirabegron is used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.”
  • “Mirabegron is a beta-3 adrenergic agonist.”
  • “Common side effects of mirabegron can include high blood pressure, urinary tract infections, headache, and constipation.”
Differentiators
Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Myrbetriq 11%
50 #2 No
DrugPatentWatch.com 9%
50 #3 No
RxList 9%
50 #4 No
NHS 9%
50 #5 No